======= KRT5 =======
== Gene Information ==
* **Official Symbol**: KRT5
* **Official Name**: keratin 5
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3852|3852]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P13647|P13647]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=KRT5&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KRT5|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/148040|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Mutations in these genes have been associated with a complex of diseases termed epidermolysis bullosa simplex. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: N/A
|Filament|
|hemidesmosome assembly|
|cell-substrate junction assembly|
|scaffold protein binding|
|keratin filament|
|structural constituent of cytoskeleton|
|cornification|
|intermediate filament|
|cell junction assembly|
|cell junction organization|
|keratinization|
|keratinocyte differentiation|
|epidermal cell differentiation|
|skin development|
|epidermis development|
|epithelial cell differentiation|
|programmed cell death|
|cell death|
|cytoskeleton organization|
|epithelium development|
|tissue development|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-2.08|
|[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-1.81|
|[[:results:exp375|Lenalidomide 20μM R07 exp375]]|1.72|
|[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|1.74|
|[[:results:exp482|Fas-L 44ng/ml R08 exp482]]|1.88|
|[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|1.9|
^Gene^Correlation^
|[[:human genes:c:cactin|CACTIN]]|0.43|
|[[:human genes:r:rad51|RAD51]]|0.429|
|[[:human genes:s:snip1|SNIP1]]|0.419|
|[[:human genes:t:tpx2|TPX2]]|0.413|
|[[:human genes:r:rrp7a|RRP7A]]|0.4|
|[[:human genes:s:snrpa1|SNRPA1]]|0.4|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2652
* **Expression level (log2 read counts)**: -6.6
{{:chemogenomics:nalm6 dist.png?nolink |}}